Bugworks Research Inc.
PrivateLast Round
Series B
Extension
Feb 8, 2022
Total Funding Raised
$34.58M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Bugworks Research Inc. is a clinical-stage biopharmaceutical company that develops novel therapeutic assets in the anti-infectives and immuno-oncology areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bugworks Research Inc. Comparables
Compare Bugworks Research Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VenatoRx | 86% | |
| Bioversys | 80% | |
| Macrolide Pharmaceuticals | 78% |
Bugworks Research Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 8, 2022 | ||||
| Series B | Apr 23, 2020 | ||||
| Series A | Aug 13, 2018 |
Bugworks Research Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| UTEC (The University of Tokyo Edge Capital Partners) | Series B Extension, Series A, Series B |
| Global Brain Corporation | Series B Extension |
| 3one4 Capital | Series A, Series B, Series B Extension |
| Global Brain | Series B |
| Centre for Cellular and Molecular Platforms | Grant |
| Lightrock India | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 103% MoM.
- Jan 8, 2026
Monthly visitors increased 713% MoM, reaching 8.3K.
Recent news
Latest coverage and updates
- attends_eventSep 12, 2026
Bugworks Research Inc. attended event Bio Tech Conclave 2026 on Sep 11th '26.
Bugworks Research Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bugworks Research Inc.'s valuation, stock price, and market status.
Is Bugworks Research Inc. a public or private company?
Bugworks Research Inc. is a private company.
What is the current stock price of Bugworks Research Inc.?
Bugworks Research Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Bugworks Research Inc. worth (valuation)?
Valuation information for Bugworks Research Inc. is not publicly available.
Can I buy Bugworks Research Inc. stock?
Bugworks Research Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bugworks Research Inc.'s last funding round?
Bugworks Research Inc.'s most recent funding round was Series B Extension on February 8, 2022.
Who are the main investors in Bugworks Research Inc.?
Key investors in Bugworks Research Inc. include UTEC (The University of Tokyo Edge Capital Partners), Global Brain, Lightrock India.
Will Bugworks Research Inc. IPO soon?
No public IPO plans have been announced for Bugworks Research Inc..
How can I track Bugworks Research Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bugworks Research Inc.'s secondary market activity and sign up for updates.